Search
Search Results
##search.searchResults.foundPlural##
-
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1355PDF: 722HTML: 191 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2738PDF: 823HTML: 6498Untitled: 206Untitled: 169Untitled: 169Untitled: 192 -
Osteolytic bone lesions – A rare presentation of AML M6.
1925PDF: 1052HTML: 7899Untitled: 186 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
8871PDF: 5957HTML: 87459Fig.1b: 164Fig.1c: 165Fig.2a: 156Fig.2b: 161Fig.4: 169Fig.2c: 158Fig.3: 163Tab.1: 212Tab.2: 191Tab.3: 177Tab.4: 198Fig1a: 158 -
OUTBREAK OF BURKHOLDERIA CEPACIA INFECTION: A SYSTEMATIC STUDY IN A HEMATOLOGY-ONCOLOGY UNIT OF A TERTIARY CARE HOSPITAL FROM EASTERN INDIA.
2069PDF: 896HTML: 388Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 194UntitOutbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern Indialed: 326Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 225Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 165Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 170Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 239 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1683PDF: 545HTML: 261 -
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
2727PDF: 936HTML: 3101flowcytometric result of peripheral blood sample: 157 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4193PDF: 1333HTML: 2025 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1171PDF: 448HTML: 129 -
-
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
1999PDF: 904HTML: 280 -
Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission
1555PDF: 720HTML: 223 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3416PDF: 851HTML: 1622figure 1: 149Untitled: 173 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2131PDF: 922HTML: 5023Cover Letter: 152Figure 2: 140Figure 1: 150Figure 3: 168Figure 4: 150Figure Legend: 165Table 1: 165Table 2: 160Table 3: 159 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4242PDF: 1449HTML: 1531Untitled: 210 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1592PDF: 707HTML: 457 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
1929PDF: 1360HTML: 246 -
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
741PDF: 477HTML: 92 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
1935PDF: 737HTML: 3101 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1024PDF: 524HTML: 1676Figures: 147Fifures Sanz: 157tables Sanz: 163Untitled: 157 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1165PDF: 732HTML: 296 -
DISTRIBUTION OF DIFFERENT PML/RAR? BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION
1404PDF: 869HTML: 2193Response to reviewers comments: 157 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2684PDF: 1754HTML: 3633Pellagatti Fig 1: 188Pellagatti Fig. 2: 188 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
390PDF: 206HTML: 71 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1279PDF: 869Suppl. Files: 432HTML: 219 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2559PDF: 736HTML: 196







